Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice

Acute coronary syndrome is a factor for poor prognosis and recurrent cardiovascular events. Adequate antiplatelet therapy is crucial in patients with the acute coronary syndrome for risk reduction. Such treatment is well described in four documents issued by the European Society of Cardiology, which...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Stanisław Tubek, Wiktor Kuliczkowski, Mariusz Gąsior, Marek Gierlotka, Jacek Kubica, Andrzej Budaj, Adam Witkowski, Krzysztof Reczuch, Piotr Ponikowski
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	guidelines antiplatelet treatment st elevation myocardial infarction non-st elevation myocardial infarction Medicine R
Acceso en línea:	https://doaj.org/article/ffaaf6b7906f489fa6478243ea717cb2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ffaaf6b7906f489fa6478243ea717cb2
record_format	dspace
spelling	oai:doaj.org-article:ffaaf6b7906f489fa6478243ea717cb22021-12-02T17:46:06ZAntiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice1734-93381897-429510.5114/aic.2021.107492https://doaj.org/article/ffaaf6b7906f489fa6478243ea717cb22021-07-01T00:00:00Zhttps://www.termedia.pl/Antiplatelets-in-acute-coronary-syndrome-in-Poland-from-guidelines-to-clinical-practice,35,44587,1,1.htmlhttps://doaj.org/toc/1734-9338https://doaj.org/toc/1897-4295Acute coronary syndrome is a factor for poor prognosis and recurrent cardiovascular events. Adequate antiplatelet therapy is crucial in patients with the acute coronary syndrome for risk reduction. Such treatment is well described in four documents issued by the European Society of Cardiology, which precisely illustrate the use of antiplatelets in the settings of ST-elevated and non-ST elevated myocardial infarction. Despite its unquestioned role in the treatment of acute coronary syndrome, recent real-world-data from Polish registries reveal poor adherence to the guidelines-recommended antiplatelet treatment in Poland. Thus, we present here a comprehensive review of the use of antiplatelets in the settings of the acute coronary syndrome. Each phase of the treatment, i.e. pre-hospital, in-hospital and post-hospital, is discussed separately for a better understanding of the decision-making process at each step. We also present unpublished data from Polish registries (e.g. PL-ACS 2019, National Registry of Procedures of Invasive Cardiology, RECEPTOmetrPEX panel) regarding adherence to the guidelines-recommended treatment in Poland, thus highlighting the points of care which should be immediately improved. It has to be stressed here that careful assessment of ischaemic and bleeding risk has to be performed in each patient with acute coronary syndrome individually and repeated at successive phases of the treatment. Only such an approach allows for appropriate antiplatelet therapy tailoring.Stanisław TubekWiktor KuliczkowskiMariusz GąsiorMarek GierlotkaJacek KubicaAndrzej BudajAdam WitkowskiKrzysztof ReczuchPiotr PonikowskiTermedia Publishing Housearticleguidelines antiplatelet treatment st elevation myocardial infarction non-st elevation myocardial infarctionMedicineRENAdvances in Interventional Cardiology, Vol 17, Iss 2, Pp 141-154 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	guidelines antiplatelet treatment st elevation myocardial infarction non-st elevation myocardial infarction Medicine R
spellingShingle	guidelines antiplatelet treatment st elevation myocardial infarction non-st elevation myocardial infarction Medicine R Stanisław Tubek Wiktor Kuliczkowski Mariusz Gąsior Marek Gierlotka Jacek Kubica Andrzej Budaj Adam Witkowski Krzysztof Reczuch Piotr Ponikowski Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
description	Acute coronary syndrome is a factor for poor prognosis and recurrent cardiovascular events. Adequate antiplatelet therapy is crucial in patients with the acute coronary syndrome for risk reduction. Such treatment is well described in four documents issued by the European Society of Cardiology, which precisely illustrate the use of antiplatelets in the settings of ST-elevated and non-ST elevated myocardial infarction. Despite its unquestioned role in the treatment of acute coronary syndrome, recent real-world-data from Polish registries reveal poor adherence to the guidelines-recommended antiplatelet treatment in Poland. Thus, we present here a comprehensive review of the use of antiplatelets in the settings of the acute coronary syndrome. Each phase of the treatment, i.e. pre-hospital, in-hospital and post-hospital, is discussed separately for a better understanding of the decision-making process at each step. We also present unpublished data from Polish registries (e.g. PL-ACS 2019, National Registry of Procedures of Invasive Cardiology, RECEPTOmetrPEX panel) regarding adherence to the guidelines-recommended treatment in Poland, thus highlighting the points of care which should be immediately improved. It has to be stressed here that careful assessment of ischaemic and bleeding risk has to be performed in each patient with acute coronary syndrome individually and repeated at successive phases of the treatment. Only such an approach allows for appropriate antiplatelet therapy tailoring.
format	article
author	Stanisław Tubek Wiktor Kuliczkowski Mariusz Gąsior Marek Gierlotka Jacek Kubica Andrzej Budaj Adam Witkowski Krzysztof Reczuch Piotr Ponikowski
author_facet	Stanisław Tubek Wiktor Kuliczkowski Mariusz Gąsior Marek Gierlotka Jacek Kubica Andrzej Budaj Adam Witkowski Krzysztof Reczuch Piotr Ponikowski
author_sort	Stanisław Tubek
title	Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
title_short	Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
title_full	Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
title_fullStr	Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
title_full_unstemmed	Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
title_sort	antiplatelets in acute coronary syndrome in poland – from guidelines to clinical practice
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/ffaaf6b7906f489fa6478243ea717cb2
work_keys_str_mv	AT stanisławtubek antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT wiktorkuliczkowski antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT mariuszgasior antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT marekgierlotka antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT jacekkubica antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT andrzejbudaj antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT adamwitkowski antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT krzysztofreczuch antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice AT piotrponikowski antiplateletsinacutecoronarysyndromeinpolandfromguidelinestoclinicalpractice
_version_	1718379566346534912

Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice

Ejemplares similares